INS and neoplasm: On the whole, metformin can induce anticancer activity through two main routes: a direct mechanism resulting from the inhibition of mitochondrial complex I and consequent suppression of adenosine triphosphate (ATP) production in prenoplastic and neoplastic cells and an indirect mechanism related to metformin insulin-lowering activity, which may slow tumour development in hyperinsulinemic patients [82].